50% Nitrous Oxide and 50% Oxygen (MEOPA) Conscious Sedation Versus Placebo in Fiberoptic Bronchoscopy
Launched by HOSPICES CIVILS DE LYON · Oct 25, 2006
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Man or woman over 18 who should undergo a fiberoptic bronchoscopy (inpatient and outpatient)
- Exclusion Criteria:
- • Child under 18
- • Pneumothorax
- • ocular surgery in the previous 3 months,
- • intracranial overpressure
- • lucidity impairment
- • emphysema bullae
- • face trauma
- • angina pectoris
- • hemodynamic instability
- • acute respiratory distress
- • hypercapnia \> 45 mm Hg
- • pregnancy
- • lidocaine allergia
- • lack of approuval from the patient to perform the study will of the patient to undergo FOB with premixed nitrous oxide-oxygen
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Trial Officials
Corinne DEPAGNE, MD
Principal Investigator
Hospices Civils de Lyon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials